According to Hanmi Pharmaceutical 's latest financial reports the company's current earnings (TTM) are $0.10 B. In 2022 the company made an earning of $59.61 M an increase over its 2021 earnings that were of $44 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.10 B | 79.62% |
2022 | $59.61 M | 35.46% |
2021 | $44 M | 58.74% |
2020 | $27.72 M | -13.39% |
2019 | $32 M | 75.68% |
2018 | $18.21 M | -40.53% |
2017 | $30.63 M | 59.25% |
2016 | $19.23 M | -90.55% |
2015 | $0.20 B | 893.8% |
2014 | $20.49 M | 88.55% |
2013 | $10.86 M | -18.11% |
2012 | $13.26 M |